News from kowa pharmaceuticals america, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Oct 28, 2014, 08:00 ET
Kowa Pharmaceuticals America, Inc. Logo

Landmark Trial To Explore The Prevention Of Heart Disease In People Living With HIV

The National Institutes of Health (NIH)/National Heart, Lung and Blood Institute (NHLBI) are initiating a landmark multimillion dollar outcomes...

Sep 24, 2014, 09:00 ET
Kowa Pharmaceuticals America, Inc. Logo (PRNewsFoto/Kowa Pharmaceuticals America)

NFL MVP Kurt Warner And Wife Challenge Football Fans To Make Tailgating Heart Healthy This Season

Kurt and Brenda Warner are giving the 71 million Americans living with high cholesterol heart-healthy tailgating tips just in time for football...

May 29, 2014, 06:30 ET
Kowa Pharmaceuticals America, Inc. Logo.  (PRNewsFoto/Kowa Pharmaceuticals America, Inc.)

NFL Legend Kurt Warner Announces First and Goal "Big Game Sweepstakes"

 National heart-health initiative, First and Goal, today announced the launch of a consumer sweepstakes encouraging those living with high...

May 01, 2014, 06:30 ET
Kowa Pharmaceuticals America, Inc. Logo. (PRNewsFoto/Kowa Pharmaceuticals America)

Data Showed After 52 Weeks, LIVALO® (pitavastatin) 4 mg Maintained Similar Safety and Significantly Greater LDL-C Reduction Compared with Pravastatin 40 mg in HIV-infected Adults with Dyslipidemia

Kowa Pharmaceuticals America, Inc. announced results of a pre-specified safety analysis from the INTREPID (HIV-infected patieNts and TREatment with...

Apr 02, 2014, 06:30 ET
Kurt Warner.  (PRNewsFoto/Kowa Pharmaceuticals America, Inc.)

NFL MVP Kurt Warner And Wife Brenda Tackle A Public Health Issue Affecting Millions Of Americans With National Cholesterol Awareness Campaign

 Kowa Pharmaceuticals America, Inc. today announced a partnership with Kurt Warner, Super Bowl winner and two-time NFL MVP, and his wife...

Jun 17, 2013, 11:30 ET
Kowa Pharmaceuticals America, Inc. Logo.  (PRNewsFoto/Kowa Pharmaceuticals America, Inc.)

New Data Showed LIVALO® (pitavastatin) 4 mg had Neutral Effects on Fasting Serum Glucose and HbA1c Levels in HIV-infected Adults with Dyslipidemia

Kowa Pharmaceuticals America, Inc. and Eli Lilly and Company (NYSE: LLY) announced results of a pre-specified safety analysis from the INTREPID...

Mar 07, 2013, 06:30 ET
Kowa Pharmaceuticals America, Inc. Logo.  (PRNewsFoto/Kowa Pharmaceuticals America, Inc.)

New Superiority Trial Showed LIVALO® (pitavastatin) 4 mg Provided Significantly Greater LDL-C Reduction in HIV-Infected Adults with Dyslipidemia versus Pravastatin 40 mg

Kowa Pharmaceuticals America, Inc. and Eli Lilly and Company (NYSE:LLY) announced results of a study evaluating the efficacy of...

Nov 05, 2012, 11:00 ET
Kowa Pharmaceuticals America, Inc. Logo.  (PRNewsFoto/Kowa Pharmaceuticals America, Inc.)

Results from the Largest Known Cholesterol Survey Conducted in the U.S. Announced at the American Heart Association's Annual Scientific Sessions

Results from the USAGE survey, the largest known cholesterol survey in the U.S. involving more than 10,100 statin users1, were presented today at...

Jul 22, 2012, 15:00 ET
Kowa Pharmaceuticals America, Inc. Logo.  (PRNewsFoto/Kowa Pharmaceuticals America, Inc.)

Pharmacokinetic Study Results Released Evaluating Interactions Between LIVALO® (pitavastatin) and Protease Inhibitor Combination (darunavir/ritonavir) in Healthy Volunteers

Kowa Pharmaceuticals America, Inc. (Kowa Pharmaceuticals) and Eli Lilly and Company (Lilly) (NYSE: LLY) today released results from a...

May 31, 2012, 06:00 ET
Kowa Pharmaceuticals America, Inc. Logo.  (PRNewsFoto/Kowa Pharmaceuticals America, Inc.)

New Data Showed LIVALO® (pitavastatin) Met Primary Endpoint of LDL-C Reduction When Compared with Pravastatin

Kowa Pharmaceuticals America, Inc. and Eli Lilly and Company (NYSE:LLY) today announced results of the PREVAIL U.S. study (Pitavastatin compaREd...

Feb 13, 2012, 06:30 ET
Kowa Pharmaceuticals America, Inc. Logo.  (PRNewsFoto/Kowa Pharmaceuticals America, Inc.)

New Study Data Published Assessing the Effect of LIVALO® vs. Crestor® on International Normalized Ratio on Steady-State Warfarin

 Kowa Pharmaceuticals America, Inc. today announced data assessing the effect of LIVALO® (pitavastatin) compared with Crestor®...

Jul 18, 2011, 05:30 ET
Kowa Pharmaceuticals America, Inc. logo. (PRNewsFoto/Kowa Pharmaceuticals America, Inc. and Eli Lilly and Company)

New Data Showed Minimal Potential for Drug Interaction Between Cholesterol Drug LIVALO® and a Common Antiretroviral Therapy

Kowa Pharmaceuticals America, Inc. and Eli Lilly and Company (NYSE: LLY) today released new study results that investigated the potential...

Jun 21, 2010, 08:00 ET
Eli Lilly and Company logo. (PRNewsFoto, Eli Lilly and Company)

Kowa Pharmaceuticals America and Lilly Announce U.S. Availability of LIVALO

Kowa Pharmaceuticals America, Inc., and Eli Lilly and Company (NYSE: LLY) today announced that LIVALO® (pitavastatin) tablets is now...

Sep 02, 2009, 07:09 ET

Study Shows LIVALO(R) is not Affected by Co-Administration of Itraconazole

LIVALO (pitavastatin) may have the potential for fewer drug-drug interactions, versus other statins, as evidenced by a new study that...

Sep 01, 2009, 08:43 ET

LIVALO(R) Demonstrates Sustained, Long-Term Efficacy and Tolerability in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia

New data presented today showed that in patients treated with LIVALO (pitavastatin), high-density lipoprotein cholesterol (HDL-C) concentrations...

Aug 04, 2009, 08:00 ET

FDA Approves LIVALO(R) for Primary Hypercholesterolemia and Combined Dyslipidemia

New statin from Kowa Pharmaceuticals America to fill an unmet need for clinically complex patient populations Kowa Research Institute (KRI)...

Aug 03, 2009, 17:52 ET

FDA Approves LIVALO(R) for Primary Hypercholesterolemia and Combined Dyslipidemia

Kowa Research Institute (KRI) based in Morrisville, NC and Kowa Pharmaceuticals America, Inc. (KPA), a privately-held specialty...

Jun 16, 2009, 08:00 ET

Study Demonstrates Efficacy of Pitavastatin in Elderly Patients

Pitavastatin represents important treatment option for more vulnerable populations New data presented today showed that pitavastatin is an...

Jun 15, 2009, 08:00 ET

Pitavastatin Demonstrates Promise for Low Incidence of Drug-Drug Interaction

Study shows Kowa's novel synthetic statin is safe and well tolerated in combination with warfarin New data presented today showed that...